Cyteir Therapeutics, Inc. (CYT) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 2 recommend buying, 1 recommend holding, and 2 recommend selling.
The analyst consensus price target for CYT is $2.00, representing a -33.8% downside from the current price of $3.02. Price targets range from a low of $2.00 to a high of $2.00.
